ArticleProceedings (Baylor University. Medical Center)2024

Efficacy and risk of osteonecrosis of the jaw for pamidronate, zoledronic acid, and denosumab in comparison to alendronate in multiple myeloma patients.

Micah Browne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.